Expansion of donor-specific TREG following pre-transplant MSC infusion. (1) MSC infused before transplant induce TREG from conventional T cells and promote a polyclonal, antigen-independent expansion; at the same time, (2) MSC inhibit dendritic cell maturation increasing the frequency of protolerogenic DCs, and (3) reprogram macrophages toward an M2 phenotype. (4) Allogeneic transplantation causes migration of donor DCs from the graft to lymphoid organs and provides alloantigen for recipient DC uptake (other antigen presenting cells can act the same way). (5) Direct and indirect antigen presentation provide the survival stimuli necessary for donor-specific TREG proliferation, while the non-alloreactive TREG pool is progressively lost over time. Protolerogenic DCs can also induce TREG from conventional alloreactive T cells, while alternatively-activated macrophage TGFβ secretion promotes TREG expansion. MSC, mesenchymal stromal cell; TCONV, conventional T cell; TREG, regulatory T cell; mDC, mature dendritic cell; tDC, tolerogenic dendritic cell; M1ϕ, classically-activated macrophage; M2ϕ, alternatively-activated macrophage; PGE2, prostaglandin-E2; IDO, indoleamine 2,3-dioxygenase; TGFβ, transforming growth factor β; HLA-G5, human leukocyte antigen G5; IL-6, interleukin 6; TSG6, tumor necrosis factor-inducible gene 6 protein.